Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982535priorityCriticalpatent/ECSP982535A/en
Publication of ECSP982535ApublicationCriticalpatent/ECSP982535A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Un método para el tratamiento y/o la profilaxia de diabetes mellitus, condiciones asociadas con la diabetes mellitus y ciertas complicaciones de la misma, en un mamífero, cuyo método comprende administrar una cantidad eficaz no tóxica y farmacéuticamente aceptables de un sensibilizador a insulina y un agente antihiperglucémico del tipo de biguanida, a un mamífero que necesita de ello, y a una composición farmacéutica que comprende un sensibilizador a insulina y un agente antihiperglucémico del tipo de biguanida.A method for the treatment and / or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus, and certain complications thereof, in a mammal, the method of which comprises administering a non-toxic and pharmaceutically acceptable effective amount of an insulin sensitizer and a biguanide-type antihyperglycemic agent, a mammal in need thereof, and a pharmaceutical composition comprising an insulin sensitizer and a biguanide-like antihyperglycemic agent.
ECSP9825351998-06-161998-06-16
NEW TREATMENT METHOD (I)
ECSP982535A
(en)
USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS.
USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT
THE USE OF A LEPTINE SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF IT FOR THE MANUFACTURING OF A MEDICATION USEFUL FOR THE TREATMENT AND / OR PROPHYLAXIS OF LEPTIN RESISTANCE AND / OR STATES ASSOCIATED WITH LEPTIN RESISTANCE AND / OR